Burberry Jumps, Qiagen Up, Rio Tinto Gains
On this episode of Stock Movers:- Burberry’s sales advanced over the key holiday period as shoppers snapped up the British brand’s tartan scarves and trench coats, especially in China, bolstering hope...
21 Jan 4min
Netflix Falls, United Airlines Rise Post-market, Boeing Recoup Losses
On this episode of Stock Movers: - Netflix (NFLX) shares fell as much as 5.1% in extended New York trading after streaming giant forecast first-quarter EPS below the average analyst estimate. The comp...
20 Jan 5min
Closing Bell: United Airlines and Netflix Report
On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greif...
20 Jan 6min
Amazon Sinks, Netflix Mixed on Amended Offer, Intel Rises
On this episode of Stock Movers: - Amazon (AMZN) sinks after Amazon CEO Andy Jassy said President Donald Trump's sweeping tariffs are starting to be reflected in the price of some items, as sellers w...
20 Jan 3min
3M Drops, Strategy Falls, ImmunityBio Drops After FDA Meeting Update
On this episode of Stock Movers:- 3M (MMM) drops after the company said its' profit outlook fell narrowly short of Wall Street’s expectations for this year. Adjusted earnings will be $8.50 to $8.70 a ...
20 Jan 3min
Netflix Rises, Applovin Slumps, Intel Rises on Ratings Upgrade
On this episode of Stock Movers:- Netflix (NFLX) shares rise after the company reached an amended, all-cash agreement to buy Warner Bros. Discovery Inc.’s studio and streaming business. The changes ar...
20 Jan 3min
3M Profit Outlook Light; Netflix Amends Warner Bros. Deal; GSK to Buy Rapt Therapeutics
On this episode of Stock Movers:- 3M (MMM) shares fall after the industrial company gave an outlook for this year’s adjusted earnings per share with a midpoint below what analysts expected. JPMorgan s...
20 Jan 3min
Rapt, 3M, D.R. Horton
On this episode of Stock Movers:- GSK (GSK) agreed to buy Rapt Therapeutics (RAPT), a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued a...
20 Jan 4min
